Ranexa
RxNorm concept 356778, brand name (bn).
- RxCUI
- 356778
- Term type
- Brand name (BN)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/356778 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Related concepts
- ranolazine 500 MG [Ranexa] (SBDC, ingredient of)
- ranolazine Extended Release Oral Tablet [Ranexa] (SBDF, ingredient of)
- ranolazine 1000 MG [Ranexa] (SBDC, ingredient of)
- 12 HR ranolazine 1000 MG Extended Release Oral Tablet [Ranexa] (SBD, ingredient of)
- 12 HR ranolazine 500 MG Extended Release Oral Tablet [Ranexa] (SBD, ingredient of)
- Ranexa Oral Product (SBDG, ingredient of)
- Ranexa Pill (SBDG, ingredient of)
- ranolazine (IN, tradename of)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 356778 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/356778 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 356778. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.